Tweaking the immune response might be a key to combat neurodegeneration
News Oct 19, 2016
Study suggests zebrafish might teach us how to tackle Alzheimer's disease -
Patients with Alzheimer’s or other neurodegenerative diseases progressively loose neurons yet cannot build new ones. However, modulating the immune response might help the human brain to better cope with such conditions and regenerate. The research group led by Caghan Kizil at the German Center for Neurodegenerative Diseases (DZNE) report on these findings in the journal Cell Reports. Their conclusions are based on studying zebrafish, an organism well-known for its ability to counteract neuronal damage by regenerating lost cells.
Zebrafish and humans are obviously quite different species. However, they share an evolutionary past that translates into various similarities on the cellular and molecular scale. "The regenerative skills apparent in zebrafish might lie dormant in humans and might somehow be activated by pulling the right strings", Kizil explains. "This is why we study if and how zebrafish cope with neurodegeneration. We want to understand the basic molecular mechanisms of such a regenerative aptitude in order to design better clinical therapies."
In the current study, the Dresden-based neuroscientist and his co-workers succeeded in mimicking symptoms of Alzheimer's disease in zebrafish brain. Conditions were triggered by Amyloid-Beta42 (Aβ42) peptides - one of the major contributors to the disease in human brains. Similar to our brains, Amyloid molecules accumulated in the neurons of zebrafish leading to immune response, synaptic degeneration, cell death, learning deficits and other dysfunctions. "This is the first time, such conditions have been generated in adult zebrafish through Aβ42 deposits", Kizil says.
Graphical abstract of the reserach. Credit: Bhattarai et al., Cell Reports, 2016
The significance of neuro-immune crosstalk
The Aβ42 deposits triggered a special inflammation-related signaling pathway that ultimately lead to enhanced neurogenesis, i.e. new neurons were built. "We found that a molecule called Interleukin-4 is very much involved in the generation of neurons. The molecule is released by the dying neurons and immune system cells. It then acts on neural stem cells, which are the progenitors of neurons, by increasing their proliferation", Kizil says. "Interleukin-4 has been known to be a player in immune response and inflammation. But to date, the direct role of IL4 on stem cell proliferation has not been shown."
A better understanding of how we could manipulate inflammatory conditions might aid to develop novel therapies against Alzheimer's, Kizil argues. "In humans inflammation does not seem to act as a positive cue for regeneration as it does in zebrafish. Possibly because other factors interfere in a complex manner. Our zebrafish model offers the opportunity to study such factors one by one in a reductionist manner. Besides, our study points to the significance of the immune response. That is to say: by tweaking the immune response, for example with drugs, and targeting the right cell types, we might unlock the potential of human neural stem cells to proliferate and build new neurons. Of course, the challenge remains as to what will happen to those new neurons. But first things first: we have to start from the stem cells."
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Bhattarai P et al. IL4/STAT6 Signaling Activates Neural Stem Cell Proliferation and Neurogenesis upon Amyloid-β42 Aggregation in Adult Zebrafish Brain. Cell Reports, Published October 18 2016. doi: 10.1016/j.celrep.2016.09.075
The Mouse Brain Can Prioritize Hunger by Suppressing Pain When Survival is at StakeNews
Researchers show that pain and hunger interact in complex ways in mice: extreme hunger suppresses less-urgent inflammatory pain, so that the mice are willing to go find food, but leaves them able to feel and react to more life-and-death kinds of pain.READ MORE
Comments | 0 ADD COMMENT
International Conference on Neuroimmunology, Neurological disorders and Neurogenetics
Sep 26 - Sep 27, 2018